-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Passed Our Checks, And It's About To Pay A CN¥0.12 Dividend
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Passed Our Checks, And It's About To Pay A CN¥0.12 Dividend
Readers hoping to buy Aier Eye Hospital Group Co., Ltd. (SZSE:300015) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Thus, you can purchase Aier Eye Hospital Group's shares before the 11th of July in order to receive the dividend, which the company will pay on the 11th of July.
The company's next dividend payment will be CN¥0.12 per share, and in the last 12 months, the company paid a total of CN¥0.12 per share. Based on the last year's worth of payments, Aier Eye Hospital Group stock has a trailing yield of around 0.3% on the current share price of CN¥42.51. If you buy this business for its dividend, you should have an idea of whether Aier Eye Hospital Group's dividend is reliable and sustainable. So we need to check whether the dividend payments are covered, and if earnings are growing.
View our latest analysis for Aier Eye Hospital Group
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Fortunately Aier Eye Hospital Group's payout ratio is modest, at just 26% of profit. A useful secondary check can be to evaluate whether Aier Eye Hospital Group generated enough free cash flow to afford its dividend. It paid out 23% of its free cash flow as dividends last year, which is conservatively low.
It's positive to see that Aier Eye Hospital Group's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
SZSE:300015 Historic Dividend July 7th 2022Have Earnings And Dividends Been Growing?
Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. That's why it's comforting to see Aier Eye Hospital Group's earnings have been skyrocketing, up 32% per annum for the past five years. Aier Eye Hospital Group is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. This is a very favourable combination that can often lead to the dividend multiplying over the long term, if earnings grow and the company pays out a higher percentage of its earnings.
The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Aier Eye Hospital Group has increased its dividend at approximately 24% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.
The Bottom Line
Has Aier Eye Hospital Group got what it takes to maintain its dividend payments? It's great that Aier Eye Hospital Group is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. It's disappointing to see the dividend has been cut at least once in the past, but as things stand now, the low payout ratio suggests a conservative approach to dividends, which we like. It's a promising combination that should mark this company worthy of closer attention.
While it's tempting to invest in Aier Eye Hospital Group for the dividends alone, you should always be mindful of the risks involved. For example - Aier Eye Hospital Group has 2 warning signs we think you should be aware of.
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
希望購買的讀者愛爾眼科醫院集團有限公司。(SZSE:300015),由於該股即將進行不含股息的交易,其股息將很快採取行動。除息日期通常被設定為記錄日期之前的一個工作日,也就是你必須作為股東出現在公司賬簿上才能獲得股息的截止日期。除息日期很重要,因為股票的任何交易都需要在記錄日期之前結算,才有資格獲得股息。因此,你可以在7月11日之前購買愛爾眼科醫院集團的股票,以便獲得股息,該公司將在7月11日支付股息。
公司下一次派息將為每股0.12元人民幣,最近12個月,公司共支付每股0.12元人民幣。根據去年的支付金額,愛爾眼科醫院集團股票的往績收益率在當前股價42.51元的基礎上約為0.3%。如果你為了分紅而收購這項業務,你應該對愛爾眼科醫院集團的分紅是否可靠和可持續有所瞭解。因此,我們需要檢查股息支付是否得到覆蓋,以及收益是否在增長。
查看我們對愛爾眼科醫院集團的最新分析
股息通常從公司收入中支付,因此,如果一家公司支付的股息超過了它的收入,它的股息通常被削減的風險更高。幸運的是,愛爾眼科醫院集團的派息率不高,僅佔利潤的26%。一個有用的次要檢查可以是評估愛爾眼科醫院集團是否產生了足夠的自由現金流來支付股息。它去年支付了23%的自由現金流作為股息,這是保守的低水平。
看到艾爾眼科醫院集團的股息由利潤和現金流覆蓋,這是積極的,因為這通常是股息可持續的跡象,較低的派息率通常意味着在股息削減之前有更大的安全邊際。
點擊此處查看該公司的派息率,以及分析師對其未來股息的估計。
深圳證券交易所:300015歷史性紅利2022年7月7日盈利和股息一直在增長嗎?
產生可持續收益增長的公司的股票往往是最好的股息前景,因為當收益上升時,提高股息更容易。如果收益下降,該公司被迫削減股息,投資者可能會眼睜睜地看着他們的投資價值化為烏有。這就是為什麼看到艾爾眼科醫院集團的收益一直在飆升,在過去五年中以每年32%的速度增長,令人欣慰。AIER眼科醫院集團支付的收益和現金流不到一半,同時每股收益快速增長。這是一個非常有利的組合,如果收益增長,公司支付的收益佔收益的比例更高,這種組合往往會導致長期股息成倍增長。
大多數投資者評估一家公司的股息前景的主要方式是檢查歷史上的股息增長率。在過去的10年裏,愛爾眼科醫院集團平均每年增加約24%的股息。令人興奮的是,過去幾年,每股收益和股息都快速增長。
底線
愛爾眼科醫院集團是否獲得了維持其股息支付的能力?艾爾眼科醫院集團在提高每股收益的同時,支付了收益和現金流的低比例,這是一件很好的事情。看到過去至少削減過一次股息令人失望,但就目前的情況來看,低派息率意味着對股息採取保守的方式,這是我們喜歡的。這是一個很有希望的組合,應該標誌着這家公司值得密切關注。
雖然投資愛爾眼科醫院集團僅僅是為了分紅是很誘人的,但你應該始終注意其中的風險。例如-愛爾眼科醫院集團2個警告標誌我們認為你應該意識到。
一個常見的投資錯誤是購買你看到的第一隻有趣的股票。在這裏你可以找到高收益股息股的完整名單。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧